These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 21164505)
1. Gp130 cytokines exert differential patterns of crosstalk in adipocytes both in vitro and in vivo. White UA; Stewart WC; Stephens JM Obesity (Silver Spring); 2011 May; 19(5):903-10. PubMed ID: 21164505 [TBL] [Abstract][Full Text] [Related]
2. Cross-talk among gp130 cytokines in adipocytes. Zvonic S; Baugh JE; Arbour-Reily P; Mynatt RL; Stephens JM J Biol Chem; 2005 Oct; 280(40):33856-63. PubMed ID: 16096272 [TBL] [Abstract][Full Text] [Related]
3. The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation. Adrian-Segarra JM; Schindler N; Gajawada P; Lörchner H; Braun T; Pöling J J Biol Chem; 2018 May; 293(18):7017-7029. PubMed ID: 29511087 [TBL] [Abstract][Full Text] [Related]
5. Novel inhibitors for murine and human leukemia inhibitory factor based on fused soluble receptors. Metz S; Naeth G; Heinrich PC; Müller-Newen G J Biol Chem; 2008 Mar; 283(10):5985-95. PubMed ID: 18174171 [TBL] [Abstract][Full Text] [Related]
6. gp130 Cytokines Activate Novel Signaling Pathways and Alter Bone Dissemination in ER+ Breast Cancer Cells. Omokehinde T; Jotte A; Johnson RW J Bone Miner Res; 2022 Feb; 37(2):185-201. PubMed ID: 34477239 [TBL] [Abstract][Full Text] [Related]
7. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130. Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060 [TBL] [Abstract][Full Text] [Related]
8. Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass. Walker EC; Johnson RW; Hu Y; Brennan HJ; Poulton IJ; Zhang JG; Jenkins BJ; Smyth GK; Nicola NA; Sims NA J Biol Chem; 2016 Oct; 291(41):21703-21716. PubMed ID: 27539849 [TBL] [Abstract][Full Text] [Related]
9. Comparative study of gp130 cytokine effects on corticotroph AtT-20 cells--redundancy or specificity of neuroimmunoendocrine modulators? Auernhammer CJ; Kopp FB; Vlotides G; Dorn F; Isele NB; Spöttl G; Cengic N; Weber MM; Senaldi G; Engelhardt D Neuroimmunomodulation; 2004; 11(4):224-32. PubMed ID: 15249728 [TBL] [Abstract][Full Text] [Related]
10. Neuropoietin activates STAT3 independent of LIFR activation in adipocytes. White UA; Stephens JM Biochem Biophys Res Commun; 2010 Apr; 395(1):48-50. PubMed ID: 20353755 [TBL] [Abstract][Full Text] [Related]
11. The gp130 receptor cytokine family: regulators of adipocyte development and function. White UA; Stephens JM Curr Pharm Des; 2011; 17(4):340-6. PubMed ID: 21375496 [TBL] [Abstract][Full Text] [Related]
12. Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor. Timmermann A; Pflanz S; Grötzinger J; Küster A; Kurth I; Pitard V; Heinrich PC; Müller-Newen G FEBS Lett; 2000 Feb; 468(2-3):120-4. PubMed ID: 10692570 [TBL] [Abstract][Full Text] [Related]
13. Differential stimulation-induced receptor localization in lipid rafts for interleukin-6 family cytokines signaling through the gp130/leukemia inhibitory factor receptor complex. Port MD; Gibson RM; Nathanson NM J Neurochem; 2007 May; 101(3):782-93. PubMed ID: 17448148 [TBL] [Abstract][Full Text] [Related]
14. Blocking gp130 signaling suppresses autotaxin expression in adipocytes and improves insulin sensitivity in diet-induced obesity. Sun S; Wang R; Song J; Guan M; Li N; Zhang X; Zhao Z; Zhang J J Lipid Res; 2017 Nov; 58(11):2102-2113. PubMed ID: 28874440 [TBL] [Abstract][Full Text] [Related]
15. Oncostatin M suppresses browning of white adipocytes via gp130-STAT3 signaling. van Krieken PP; Odermatt TS; Borsigova M; Blüher M; Wueest S; Konrad D Mol Metab; 2021 Dec; 54():101341. PubMed ID: 34547509 [TBL] [Abstract][Full Text] [Related]
16. OSM/OSMR and Interleukin 6 Family Cytokines in Physiological and Pathological Condition. Lantieri F; Bachetti T Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232392 [TBL] [Abstract][Full Text] [Related]
17. Effects of leukemia inhibitory factor on 3T3-L1 adipocytes. Hogan JC; Stephens JM J Endocrinol; 2005 Jun; 185(3):485-96. PubMed ID: 15930175 [TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin m in human adipose tissue in vitro and in murine adipose tissue in vivo. Rega G; Kaun C; Demyanets S; Pfaffenberger S; Rychli K; Hohensinner PJ; Kastl SP; Speidl WS; Weiss TW; Breuss JM; Furnkranz A; Uhrin P; Zaujec J; Zilberfarb V; Frey M; Roehle R; Maurer G; Huber K; Wojta J Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1587-95. PubMed ID: 17525365 [TBL] [Abstract][Full Text] [Related]
19. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor. Wang Y; Robledo O; Kinzie E; Blanchard F; Richards C; Miyajima A; Baumann H J Biol Chem; 2000 Aug; 275(33):25273-85. PubMed ID: 10854424 [TBL] [Abstract][Full Text] [Related]